Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Alzamend Neuro, Inc. (ALZN) had Debt to Equity Ratio of -0.12 for the most recently reported fiscal year, ending 2024-04-30.
| Income Statement Financials | |
-- |
|
$-9.95M |
|
-- |
|
-- |
|
$9.94M |
|
$-9.94M |
|
$-0.01M |
|
$-9.95M |
|
$-9.95M |
|
$-9.95M |
|
$-9.95M |
|
$-9.95M |
|
$-9.95M |
|
$-9.94M |
|
$-9.89M |
|
0.08M |
|
0.08M |
|
$-132.31 |
|
$-132.31 |
|
| Balance Sheet Financials | |
$0.46M |
|
$0.18M |
|
$0.18M |
|
$0.63M |
|
$3.23M |
|
-- |
|
-- |
|
$3.23M |
|
$-2.59M |
|
$-2.59M |
|
$-2.59M |
|
0.08M |
|
| Cash Flow Statement Financials | |
$-8.27M |
|
$-0.15M |
|
$3.65M |
|
$5.14M |
|
$0.38M |
|
$-4.76M |
|
$0.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-0.12 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
383.46% |
|
383.46% |
|
-1575.04% |
|
383.46% |
|
$-33.94 |
|
$-111.98 |
|
$-110.02 |
|